SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001104659-24-023870
Filing Date
2024-02-14
Accepted
2024-02-14 16:50:49
Documents
1
Effectiveness Date
2024-02-14
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 10306
  Complete submission text file 0001104659-24-023870.txt   11673
Mailing Address 300 PARK AVENUE 2ND FLOOR NEW YORK NY 10022
Business Address 300 PARK AVENUE 2ND FLOOR NEW YORK NY 10022 (646) 293-2100
SEELOS THERAPEUTICS, INC. (Filer) CIK: 0001017491 (see all company filings)

IRS No.: 870449967 | State of Incorp.: NV | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-505332 | Film No.: 24639779
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)